Positive News Sentiment NASDAQ:SILK Silk Road Medical Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. $38.94 +2.55 (+7.01%) (As of 07/1/2022 12:00 AM ET) Add Compare Share Today's Range$35.88▼$39.0650-Day Range$28.03▼$40.1352-Week Range$27.21▼$67.49Volume214,974 shsAverage Volume351,218 shsMarket Capitalization$1.37 billionP/E RatioN/ADividend YieldN/APrice Target$50.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Silk Road Medical Stock Forecast (MarketRank)Analyst RatingModerate Buy2.60 Rating ScoreUpside/Downside28.4% Upside$50.00 Price TargetShort InterestBearish7.58% of Float Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$1.30 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.77) to ($1.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.2.09 out of 5 starsMedical Sector894th out of 1,429 stocksSurgical & Medical Instruments Industry95th out of 138 stocks 3.3 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $50.00, Silk Road Medical has a forecasted upside of 28.4% from its current price of $38.94.Amount of Analyst CoverageSilk Road Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.58% of the float of Silk Road Medical has been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Silk Road Medical has recently increased by 17.43%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 2.7 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Silk Road Medical this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for SILK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -86% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,301,100.00 in company stock.Percentage Held by InsidersOnly 7.70% of the stock of Silk Road Medical is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.77) to ($1.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -24.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -24.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 17.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address About Silk Road Medical (NASDAQ:SILK)Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.Read More SILK Stock News HeadlinesJune 17, 2022 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Trading Up 6.9%June 15, 2022 | finance.yahoo.comSilk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCARJune 9, 2022 | finance.yahoo.comDespite recent gains, Silk Road Medical, Inc (NASDAQ:SILK) insiders are still down US$8.9k after purchasing last yearJune 2, 2022 | finance.yahoo.comSilk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk PatientsMay 31, 2022 | finance.yahoo.comSilk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt FinancingMay 17, 2022 | seekingalpha.comSilk Road Medical, Inc 2022 Q1 - Results - Earnings Call PresentationMay 17, 2022 | markets.businessinsider.comAnalyst Ratings for Silk Road MedicalMay 10, 2022 | finance.yahoo.comInvestors one-year losses grow to 41% as the stock sheds US$396m this past weekMay 4, 2022 | finance.yahoo.comSilk Road Medical Reports First Quarter 2022 Financial ResultsMay 3, 2022 | morningstar.comSilk Road Medical Shares Surge on Expanded Enroute ApprovalMay 2, 2022 | marketwatch.comSilk Road Medical Shares Surge on Expanded Enroute Approval >SILKMay 2, 2022 | seekingalpha.comSilk Road Medical says FDA expanded approval for stent systemMay 2, 2022 | finance.yahoo.comSilk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent SystemSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees352Year FoundedN/ACompany Calendar Last Earnings5/04/2022Today7/02/2022Next Earnings (Estimated)8/04/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$50.00 High Stock Price Forecast$66.00 Low Stock Price Forecast$33.00 Forecasted Upside/Downside+28.4%Consensus RatingModerate Buy Rating Score (0-4)2.6 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-49.81 million Net Margins-51.93% Pretax Margin-51.93% Return on Equity-67.38% Return on Assets-35.24% Debt Debt-to-Equity Ratio0.57 Current Ratio4.33 Quick Ratio3.73 Sales & Book Value Annual Sales$101.47 million Price / Sales13.48 Cash FlowN/A Price / Cash FlowN/A Book Value$2.27 per share Price / Book17.15Miscellaneous Outstanding Shares35,116,000Free Float32,412,000Market Cap$1.37 billion OptionableNot Optionable Beta1.59 Silk Road Medical Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Silk Road Medical stock. View analyst ratings for Silk Road Medical or view top-rated stocks. What is Silk Road Medical's stock price forecast for 2022? 5 brokers have issued 1 year price targets for Silk Road Medical's shares. Their SILK stock forecasts range from $33.00 to $66.00. On average, they expect Silk Road Medical's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 28.4% from the stock's current price. View analysts' price targets for Silk Road Medical or view top-rated stocks among Wall Street analysts. How has Silk Road Medical's stock performed in 2022? Silk Road Medical's stock was trading at $42.61 at the beginning of the year. Since then, SILK shares have decreased by 8.6% and is now trading at $38.94. View the best growth stocks for 2022 here. When is Silk Road Medical's next earnings date? Silk Road Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Silk Road Medical. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Wednesday, May, 4th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $0.07. The firm earned $28 million during the quarter, compared to the consensus estimate of $27.10 million. Silk Road Medical had a negative net margin of 51.93% and a negative trailing twelve-month return on equity of 67.38%. The business's revenue was up 39.7% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.31) EPS. View Silk Road Medical's earnings history. What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $127.00 million-$132.00 million, compared to the consensus revenue estimate of $129.54 million. Who are Silk Road Medical's key executives? Silk Road Medical's management team includes the following people: Ms. Erica J. Rogers, Pres, CEO & Director (Age 58, Pay $987.28k) (LinkedIn Profile)Mr. Lucas W. Buchanan, CFO & COO (Age 45, Pay $790.27k) (LinkedIn Profile)Mr. Andrew S. Davis, Chief Commercial Officer (Age 53, Pay $777.22k) (LinkedIn Profile)Mr. Richard M. Ruedy, Exec. VP of Clinical, Regulatory Affairs & Quality Assurance (Age 55, Pay $449.68k) (LinkedIn Profile)Ms. Mhairi L. Jones, VP of Fin. & AccountingMr. Matthew McCarthy, VP of MarketingMs. Alison Highlander, VP of HRDr. Sumaira MacDonald, Exec. Medical DirectorDr. William Whealon Ph.D., Exec. VP of R&DLynn Lewis, Investors Relations Officer Who are some of Silk Road Medical's key competitors? Some companies that are related to Silk Road Medical include Inspire Medical Systems (INSP), Penumbra (PEN), Integra LifeSciences (IART), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Haemonetics (HAE), iRhythm Technologies (IRTC), Merit Medical Systems (MMSI), Axonics (AXNX), NuVasive (NUVA), Glaukos (GKOS), Beauty Health (SKIN), AtriCure (ATRC) and Nevro (NVRO). View all of SILK's competitors. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." How do I buy shares of Silk Road Medical? Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $38.94. How much money does Silk Road Medical make? Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.37 billion and generates $101.47 million in revenue each year. The company earns $-49.81 million in net income (profit) each year or ($1.61) on an earnings per share basis. How many employees does Silk Road Medical have? Silk Road Medical employs 352 workers across the globe. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for Silk Road Medical is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at [email protected], or via fax at 408-720-9013. This page (NASDAQ:SILK) was last updated on 7/2/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
